Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment

Methotrexate (MTX) is one of the staples of pediatric acute lymphoblastic leukemia (ALL) treatment. MTX targets the folate metabolic pathway (FMP). Abnormal function of the enzymes in FMP, due to genetic aberrations, leads to adverse drug reactions. The aim of this study was to investigate variants...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Genes (Basel)
Autors principals: Kotur, Nikola, Lazic, Jelena, Ristivojevic, Bojan, Stankovic, Biljana, Gasic, Vladimir, Dokmanovic, Lidija, Krstovski, Nada, Milosevic, Goran, Janic, Dragana, Zukic, Branka, Pavlovic, Sonja
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7230684/
https://ncbi.nlm.nih.gov/pubmed/32344632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes11040468
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars